Zelira Therapeutics Limited

Zelira Therapeutics Limitedverified

ZLD.AX

Price:

$0.63

Market Cap:

$7.15M

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of various medical conditions in Australia. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. The company also provides OTC products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as ITURA, an advanced relief cream formula that targets multi-symptoms, such as numbness and tingling, muscle cramps, insensitivities, and pain associated with Peripheral Artery Disease and di...[Read more]

Industry

Biotechnology

IPO Date

2003-07-25

Stock Exchange

ASX

Ticker

ZLD.AX

The PE Ratio as of January 2025 (TTM) for Zelira Therapeutics Limited (ZLD.AX) is -0.20

According to Zelira Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.20. This represents a change of -73.12% compared to the average of -0.74 of the last 4 quarters.

Zelira Therapeutics Limited (ZLD.AX) Historical PE Ratio (quarterly & annually)

How has ZLD.AX PE Ratio performed in the past?

The mean historical PE Ratio of Zelira Therapeutics Limited over the last ten years is -7.67. The current -0.20 PE Ratio has changed 160.59% with respect to the historical average. Over the past ten years (40 quarters), ZLD.AX's PE Ratio was at its highest in in the January 2011 quarter at 976.19. The PE Ratio was at its lowest in in the December 2017 quarter at -35.72.

Quarterly (TTM)
Annual

Average

-7.67

Median

-4.73

Minimum

-39.29

Maximum

-0.10

Zelira Therapeutics Limited (ZLD.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Zelira Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 559.93%

Maximum Annual PE Ratio = -0.10

Minimum Annual Increase = -96.25%

Minimum Annual PE Ratio = -39.29

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.10-96.25%
2023-2.73317.71%
2022-0.65-88.81%
2021-5.84-10.60%
2020-6.53-26.53%
2019-8.89-77.37%
2018-39.29559.93%
2017-5.9589.12%
2016-3.15-12.97%
2015-3.628.81%

Zelira Therapeutics Limited (ZLD.AX) Average PE Ratio

How has ZLD.AX PE Ratio performed in the past?

The current PE Ratio of Zelira Therapeutics Limited (ZLD.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.16

5-year avg

-3.17

10-year avg

-7.67

Zelira Therapeutics Limited (ZLD.AX) PE Ratio vs. Peers

How is ZLD.AX’s PE Ratio compared to its peers?

Zelira Therapeutics Limited’s PE Ratio is greater than Creso Pharma Limited (-0.40), greater than MGC Pharmaceuticals Limited (-0.57), greater than Botanix Pharmaceuticals Limited (-51.89), greater than Cann Group Limited (-0.32), greater than Althea Group Holdings Limited (-0.43),

Build a custom stock screener for Zelira Therapeutics Limited (ZLD.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zelira Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zelira Therapeutics Limited (ZLD.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zelira Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Zelira Therapeutics Limited's PE Ratio?

How is the PE Ratio calculated for Zelira Therapeutics Limited (ZLD.AX)?

What is the highest PE Ratio for Zelira Therapeutics Limited (ZLD.AX)?

What is the 3-year average PE Ratio for Zelira Therapeutics Limited (ZLD.AX)?

What is the 5-year average PE Ratio for Zelira Therapeutics Limited (ZLD.AX)?

How does the current PE Ratio for Zelira Therapeutics Limited (ZLD.AX) compare to its historical average?